Finnish cancer immunotherapy specialist Valo Therapeutics Oy has raised €19 million (US$20.7 million) in a round that attracted Italian and Australian investors, and funding the company to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results